<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03286348</url>
  </required_header>
  <id_info>
    <org_study_id>GINS-1001</org_study_id>
    <nct_id>NCT03286348</nct_id>
  </id_info>
  <brief_title>Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer</brief_title>
  <official_title>Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hubei Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effectiveness of close and intense monitoring on nutritional status of&#xD;
      gastrointestinal cancer patients during chemoradiotherapy (CRT), 500 CRT patients diagnosed&#xD;
      with gastrointestinal system are going to be recruited into this prospective study.&#xD;
      Patient-generated subjective global assessment (PG-SGA) scale and nutrition risk screening&#xD;
      (NRS-2002) are used for nutritional assessment at the beginning and the end of CRT; Beside&#xD;
      the nutritional parameters, Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and gastric&#xD;
      cancer module (QLQ-STO22) are used to measure quality of life in patients with gastric cancer&#xD;
      while EORTC QLQ-C30 and Colorectal Cancer-Specific Quality of Life Questionnaire (QLQ-CR38)&#xD;
      give assessment in colorectal cancer. The acute and late radiation toxicities were evaluated&#xD;
      based on Conmon terminology criteria (CTC V3.0) and the toxicity criteria of RTOG/EORTC,&#xD;
      respectively. Follow-ups every 3-6 months until three years after chemoradiotherapy are&#xD;
      involved. Response Evaluation Criteria in Solid Tumors (RECIST) guidelines are used for&#xD;
      response assessment. The primary endpoints are 3-year local control, disease-free survival,&#xD;
      distant metastasis and overall survival rate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Local Control rate</measure>
    <time_frame>From date of randomization until the date of first documented pelvic failure, assessed up to 3 years</time_frame>
    <description>Number of participants with abdominal or pelvic failure after surgery, evaluated using Kaplan-Meier Curve</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-free Survival</measure>
    <time_frame>From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>From date of randomization until the date of death from any cause, assessed up to 3 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Nutritional Status</condition>
  <condition>Gastrointestinal Cancer</condition>
  <condition>Chemoradiotherapy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        gastric cancer patients and rectal cancer patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for Gastric Cancer:&#xD;
&#xD;
          -  pathological confirmed adenocarcinoma&#xD;
&#xD;
          -  clinical stage T3-4 and/or N+ after radical surgery&#xD;
&#xD;
          -  without distance metastases&#xD;
&#xD;
          -  KPS &gt;=70&#xD;
&#xD;
          -  without previous radiotherapy&#xD;
&#xD;
          -  sign the inform consent&#xD;
&#xD;
        Inclusion Criteria for Rectal Cancer:&#xD;
&#xD;
          -  pathological confirmed adenocarcinoma&#xD;
&#xD;
          -  clinical stage T3-4 and/or N+&#xD;
&#xD;
          -  the distance from anal verge less than 12 cm&#xD;
&#xD;
          -  without distance metastases&#xD;
&#xD;
          -  KPS &gt;=70&#xD;
&#xD;
          -  without previous anti-cancer therapy&#xD;
&#xD;
          -  sign the inform consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy or breast-feeding women&#xD;
&#xD;
          -  serious medical illness&#xD;
&#xD;
          -  baseline blood and biochemical indicators do not meet the following criteria:&#xD;
             neutrophils≥1.5×10^9/L, Hb≥90g/L, PLT≥100×10^9/L, ALT/AST ≤2.5 ULN, Cr≤ 1 ULN&#xD;
&#xD;
          -  DPD deficiency&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zhen Zhang</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenjie Sun, MD</last_name>
      <phone>862164175590</phone>
      <phone_ext>1606</phone_ext>
      <email>617057654@qq.com</email>
    </contact>
    <investigator>
      <last_name>Zhen Zhang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>September 15, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2017</study_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Zhen Zhang</investigator_full_name>
    <investigator_title>MD, PHD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

